Navigation Links
Allison shares inaugural Tang Prize for his cancer immunotherapy innovation
Date:6/20/2014

The first Tang Prize for Biopharmaceutical Science has been awarded to Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center and Tasuku Honjo, M.D., Ph.D., of Japan's Kyoto University for their research leading to cancer immunotherapy.

"Both scholars' discoveries have opened a new therapeutic era in medicine," said Lee Yuan-tseh, Ph.D., Taiwan's winner of the 1986 Nobel Prize in chemistry, at the award announcement in Taipei, Taiwan, this week.

Taiwanese entrepreneur Samuel Yin established the biennial Tang Prize in December 2012. The 2014 prizes provide a cash award of NT$40 million ($1.3 million) and research grant of NT$10 million.

Allison launched an entirely new way to treat cancer by blocking molecules on immune system T cells that turn off immune response. The treatment, called immune checkpoint blockade, grew out of his basic science research to understand the biology of T cells the immune system's customized attackers.

"Receiving the Tang Prize is a great honor for me, as well as recognition of the growing importance of cancer immunotherapy," Allison said.

Allison developed an antibody to block CTLA-4, an off-switch on T cells, to unleash immune attack on tumors. Ipilimumab, a drug based on his antibody, has extinguished untreatable late-stage melanoma in 22 percent of patients in clinical trials for three years or longer, unprecedented results. The U.S. Food and Drug Administration approved the drug, now called Yervoy, for metastatic melanoma in 2011. Honjo discovered the second immune checkpoint on T cells, called PD1. A variety of experimental drugs to block PD1 and its activating ligand, PD-L1, are showing great promise in clinical trials.

Allison and Honjo were selected from hundreds of international nominees for the award, which recognizes original research that has led to significant advances in preventing, diagnosing and treating major human disea
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Cancer immunotherapy leader Allison to receive 2014 Szent-Gyorgyi Prize
2. MD Anderson researcher Jim Allison wins Breakthrough Prize for his innovative cancer immunology rese
3. Allison Kennedy Zeitlin & Company Realtors Hosts Gentle Carousel Mini Therapy Horses
4. The Economist honors cancer immunotherapy pioneer James Allison
5. T cell biology pioneer Allison wins first AACR honor for cancer immunology
6. Forbes Living TV Host Forbes Riley Shares Top Rated House Wares
7. Victory Over Violence: New Book, "Traveling with the Life-Giver" Shares How to Heal After Domestic Abuse
8. New Book "Donald's Story" Shares How to Caregive While Managing Business and Home Life
9. New Book "This Life's Tempestuous Sea" Shares How Fixing Social Problems Can Improve Health
10. Mold Shuts Down 8 Loughman Oaks Elementary School Classrooms, My Cleaning Products Shares Mold Removal Tip How Others Could Prevent Same Problem
11. “Tips To Become A Patient Person,” a New Article on Vkool.Com, Shares Tips with People on How to Be More Patient - V-kool
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Allison shares inaugural Tang Prize for his cancer immunotherapy innovation
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s largest healthcare ... lab testing and precision medicine solutions that can help pharmacists and other healthcare ... than 8.6 million adverse drug events are reported in the U.S. Pharmacogenetic ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... the largest online retailer of nutritional supplements, has officially opened the polls ... 11 awards in the following categories:, ,     Brand of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched the ... as well as announced the date of its next major release. , Version ... management tasks as well as enhancements to the customer experience. Users now ...
(Date:8/3/2015)... Alachua, FL (PRWEB) , ... August 03, 2015 , ... ... peripheral nerve injuries, is scheduled to present at the Wedbush Healthcare Conference on Wednesday, ... , A live webcast and subsequent archived replay of the Company’s presentation may be ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug Administration (FDA) ... similar to deoxycholic acid, which occurs naturally in the body and helps absorb and ... this area of the body. These are invasive procedures and very expensive for most ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Novatus Unveils Milestone Software Release 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3
... Over 400 personnel of the Central Reserve Police Force (CRPF), ... to drugs and alcohol// , according to an internal survey. ... number of men who have become drug dependent and found ... ,He said the survey was started in February ...
... There appears to be no conclusive proof that ... researchers from the American Cancer Society//. This is ... ,Though many medical specialists still prescribe vitamins ... Jacobs, senior epidemiologist and vitamin specialist with the ...
... There is no need for a malaria hospital in Kolkata ... L Joshi, Director of National Vector Born Disease Control Programme. ... dengue and malaria, Joshi said last year in Kolkata only ... the corresponing year was 73., ,Reprentatives of UP, Bihar, ...
... patients who would have to fork out much less ... Merck and Pfizer losing// their patent on drugs commanding ... Ranbaxy and Dr Reddy's Laboratories are being touted as ... vacuum created by the patent expiry of two biggest ...
... for Genetic Engineering and Biotechnology (CIGB) has registered the ... production of an anti-hepatitis B vaccine. // ... a true world scientific breakthrough, and it was obtained ... process required for it. , ,At a press ...
... new study, men with prostate cancer are more influenced ... //from trusting on clinical trial evidences. ... and comparing the anecdotal experiences of others with prostate ... treatment options were entirely different from them are the ...
Cached Medicine News:Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:8/3/2015)... , Aug. 3, 2015 Biosensors International ... SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer ... financial results for its first fiscal quarter ended ... Quarter Highlights and Recent Developments: ... improving its cost structure, driven by lower operating ...
(Date:8/3/2015)... 3, 2015 /OFF HOLD ... LLC, PIV757417 The following release: "Biotech Advancements Coupled ... Products & Treatments for Critical-Care Patients With Severe ... 3 Aug 2015 12:30 GMT Cooperative ... surgical research and top-tier universities for identifying biotech ...
(Date:8/3/2015)...  Array BioPharma Inc. (NASDAQ: ARRY ) ... full year of its fiscal year ended June ... of Array, noted, "Binimetinib and encorafenib, two innovative ... for regulatory submissions in 2016. Additional data shared ... colorectal cancer further validate the value of these ...
Breaking Medicine Technology:Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... Heavy babies have more birth complications; they are also ... PORTLAND, Ore., Oct. 31 A study by ... 40,000 women and their,babies found that women who gained ... as likely to have a heavy baby. Published in,the ...
... Bulletin Board: VRML) announced today that it has ... Agreement between the parties,through October, 2009. This extension ... development and commercialization of two tests, OVA1(TM) and,VASCLIR(TM)., ... women with ovarian tumors that,are at high risk ...
Cached Medicine Technology:Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby 2Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4
Ideal for breast compression and contouring breast cups....
Ideal for breast compression with adjustable hook and eye closure....
Female Mini-VEST, Front Closure, X-Firm...
Male Support Brief...
Medicine Products: